- Published at
- by gurufocus.com
positive
positive
CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
Phase 1 clinical trial of CMP-CPS-001 in Urea Cycle Disorders (UCDs) ongoing, with dosing completed in multiple ascending dose (MAD) cohort 3; safety, pharmacok